Brigham Buhler

Brigham Buhler, a healthcare entrepreneur and CEO of Ways2Well, shares eye-opening insights into the American healthcare crisis. He discusses how profit-driven motives lead to exorbitant costs and rampant prescription drug reliance. Buhler reveals the shocking truth behind America's highest bankruptcy rates linked to medical bills. He also critiques the roles of big pharma and emphasizes lifestyle changes over medications in mental health. The conversation highlights the stark disparities between U.S. and U.K. healthcare, advocating for substantial reforms to prioritize patient well-being.

Brigham Buhler, founder of Ways2Well and ReviveRx, joins for a fast-moving talk on peptide policy, testosterone myths, and how pharma lobbying shapes access to treatment. They get into GLP-1 battles, preventive care outside insurance, stem cells in states like Texas, AI-driven longevity, gene tweaking, Muse cells, and plasmapheresis.

Brigham Buhler, founder of Ways2Well and cofounder of ReviveRx pharmacy, dives into the complexities of chronic disease and the American healthcare system. He shares compelling insights from his Senate testimony, highlighting the urgency for reform and advocating for patient-driven narratives. The conversation explores the powerful link between diet and health, the need for accountability in healthcare, and the ethical dilemmas posed by corporate influence. Buhler emphasizes the importance of open dialogue and holistic approaches to wellness, urging listeners to engage critically with health and nutrition.

Brigham Buhler, a healthcare advocate from the White House, discusses the future of healthcare through the lens of peptides and biological optimization. He highlights remarkable safety data from over 75,000 patients, revealing zero adverse events compared to pharmaceuticals. The conversation touches on the significant shift in perceptions around peptides, previously deemed controversial. Buhler emphasizes the importance of informed choices in health and the potential for AI to revolutionize healthcare, particularly in early disease detection.

Brigham Buhler, founder of Ways2Well and ReviveRx, discusses the transformative potential of regenerative medicine and stem cell therapies. He shares personal anecdotes about his journey from pharmaceutical sales to advocating for patient-centered care. The conversation delves into the shift from personalized medicine to profit-driven healthcare, emphasizing the need for ethical practices. Buhler also highlights the importance of hormone optimization and innovative treatments like peptides, advocating for a holistic approach to health and wellness.

Brigham Buhler, healthcare entrepreneur who built Ways2Well and ReviveRX to bypass broken insurance systems. He digs into how pharmacy middlemen and rebates jack up drug costs. He describes cash-pay compounding, advanced diagnostics, regenerative therapies like plasmapheresis and Muse cells. He also discusses AI to scale personalized care and the clinic’s prevention-first model.

Brigham Buhler, healthcare entrepreneur and founder/CEO of Ways2Well, digs into how insurance and PBMs inflate drug prices and block prevention. He discusses cash-pay workarounds, peptide and stem cell regulation fights, FDA and industry capture, and blending diagnostics, AI and therapies to reclaim patient sovereignty.

Brigham Buhler, founder of Ways2Well and cofounder of ReviveRx, dives deep into the complex world of healthcare. He critiques the ethical challenges within the medical industrial complex while discussing the innovative potential of peptide therapy for non-addictive treatments. Buhler highlights the role of AI in revolutionizing patient care and shares insights on brain health and stem cell therapy's revolutionary impact on athletic recovery. With a focus on personalized medicine and patient advocacy, he envisions a transparent and accountable healthcare future.

Brigham Buhler, the founder of Ways2Well, dives into the flaws of the American healthcare system, emphasizing how profit motives undermine patient care. He reveals shocking truths about the opioid crisis and warns of misleading antidepressant prescriptions. Buoyed by personal tragedies, he calls for a shift towards preventative care and transparency. The conversation also touches on the troubling relationships between pharma and food industries, advocating for personalized medicine and deeper patient engagement in health decisions.

RFK Jr dissects America's greedy, misguided health insurance system with expert Brigham Buhler. They explore unethical practices of big pharma, broken pharmacy benefit managers, doctors operating outside the insurance system, FDA's influence on drug availability, medication bans, the opioid crisis, corrupt practices, and challenges faced in the health insurance system.